Nishiyama Y - Search Results

1

Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy.

Hasegawa Y, Nishiyama Y, Imaizumi K, Ono N, Kinoshita T, Hatano S, Saito H, Shimokata K. Hasegawa Y, et al. Among authors: nishiyama y. Cancer Gene Ther. 2000 Apr;7(4):557-62. doi: 10.1038/sj.cgt.7700134. Cancer Gene Ther. 2000. PMID: 10811473

2

Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.

Ono N, Iwayama S, Suzuki K, Sekiyama T, Nakazawa H, Tsuji T, Okunishi M, Daikoku T, Nishiyama Y. Ono N, et al. Among authors: nishiyama y. Antimicrob Agents Chemother. 1998 Aug;42(8):2095-102. doi: 10.1128/AAC.42.8.2095. Antimicrob Agents Chemother. 1998. PMID: 9687413 Free PMC article.

3

On the association of human beta 2 microglobulin with cell culture-grown human cytomegalovirus (HCMV).

Yamashita Y, Shimokata K, Nishiyama Y. Yamashita Y, et al. Among authors: nishiyama y. Virology. 1992 Sep;190(1):449-53. doi: 10.1016/0042-6822(92)91232-j. Virology. 1992. PMID: 1326812

4

Inhibition of influenza A virus replication by a kanamycin derivative.

Yamada Y, Shimokata K, Yamada Y, Yamamoto N, Goshima F, Nishiyama Y. Yamada Y, et al. Among authors: nishiyama y. Antiviral Res. 1991 Mar-Apr;15(3):171-82. doi: 10.1016/0166-3542(91)90064-x. Antiviral Res. 1991. PMID: 1888175

5

Establishment and characterization of resistant cells to etoposide (VP16) from a mouse breast cancer cell line, FM3A.

Takagi E, Kawatsu H, Shimokata K, Nishiyama Y, Kojima K, Yoshida S. Takagi E, et al. Among authors: nishiyama y. Jpn J Cancer Res. 1988 Aug;79(8):938-44. doi: 10.1111/j.1349-7006.1988.tb00058.x. Jpn J Cancer Res. 1988. PMID: 2846485 Free PMC article.

6

Critical involvement of CD40 in protection against herpes simplex virus infection in a murine model of genital herpes.

Inagaki-Ohara K, Kawabe T, Hasegawa Y, Hashimoto N, Nishiyama Y. Inagaki-Ohara K, et al. Among authors: nishiyama y. Arch Virol. 2002;147(1):187-94. doi: 10.1007/s705-002-8311-3. Arch Virol. 2002. PMID: 11855631

7

Down-regulation of the surface expression of class I MHC antigens by human cytomegalovirus.

Yamashita Y, Shimokata K, Mizuno S, Yamaguchi H, Nishiyama Y. Yamashita Y, et al. Among authors: nishiyama y. Virology. 1993 Apr;193(2):727-36. doi: 10.1006/viro.1993.1181. Virology. 1993. PMID: 8384753

8

Antiherpesvirus activities of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) in cell culture.

Iwayama S, Ono N, Ohmura Y, Suzuki K, Aoki M, Nakazawa H, Oikawa M, Kato T, Okunishi M, Nishiyama Y, Yamanishi K. Iwayama S, et al. Among authors: nishiyama y. Antimicrob Agents Chemother. 1998 Jul;42(7):1666-70. doi: 10.1128/AAC.42.7.1666. Antimicrob Agents Chemother. 1998. PMID: 9661001 Free PMC article.

9

Evaluation of anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]- guanine (A-5021) in mice.

Iwayama S, Ohmura Y, Suzuki K, Ono N, Nakazawa H, Aoki M, Tanabe I, Sekiyama T, Tsuji T, Okunishi M, Yamanishi K, Nishiyama Y. Iwayama S, et al. Among authors: nishiyama y. Antiviral Res. 1999 Jun;42(2):139-48. doi: 10.1016/s0166-3542(99)00024-8. Antiviral Res. 1999. PMID: 10389656

10

Pathogenesis of cytomegalovirus-associated pneumonitis in ICR mice: possible involvement of superoxide radicals.

Ikeda T, Shimokata K, Daikoku T, Fukatsu T, Tsutsui Y, Nishiyama Y. Ikeda T, et al. Among authors: nishiyama y. Arch Virol. 1992;127(1-4):11-24. doi: 10.1007/BF01309571. Arch Virol. 1992. PMID: 1333750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,811 results

Search Page

Filters